2023년 7월 14일
Elevating Probiotic Research and Innovation in Functional Foods
In a significant stride towards global recognition, Ildong Bioscience, a subsidiary of the Ildong Pharmaceutical Group's health functional food division, has achieved a momentous milestone by obtaining raw material certification in the United States. The company proudly announced on the 13th of this month that it has been awarded the esteemed 'FDA GRAS' (Generally Recognized As Safe) certification for its probiotic raw materials, reinforcing its commitment to ensuring safety and quality in the realm of functional foods.
FDA GRAS Certification: A Mark of Safety and Trust
The FDA GRAS certification stands as a cornerstone of trust within the food and health industries, showcasing that specific substances are acknowledged by the United States Food and Drug Administration (FDA) as being safe for use as raw materials in various applications, including food products.
The spotlight of this certification rests on Ildong Bioscience's probiotics raw materials, namely Lactobacillus rhamnosus 'IDCC 3201' and Bifidobacterium lactis 'IDCC 4301'. These components serve as functional materials integral to the creation of diverse products, notably health functional foods that cater to the intricate realm of intestinal health.
Pioneering Probiotic Innovation: Lactobacillus rhamnosus IDCC 3201
One of the certified probiotics, Lactobacillus rhamnosus IDCC 3201, stands as a testament to Ildong Bioscience's pioneering research and development efforts. An original strain of probiotics conceived by the company, this unique microorganism has garnered attention not only for its potential in promoting intestinal health but also for its multifaceted benefits. The strain boasts an array of registered patents encompassing areas such as immune regulation, inhibition of Helicobacter pylori and vaginitis-causing bacteria, and even vitamin (B1) production. These patents underline the far-reaching impact and versatility of Ildong Bioscience's probiotic research.
Bifidobacterium lactis IDCC 4301: Tackling Health Challenges Head-On
In the case of Bifidobacterium lactis IDCC 4301, the scope of innovation extends to addressing significant health challenges. This probiotic strain has not only gained recognition for its potential in reducing body fat in humans but also for its role in improving obesity in companion animals. The company's dedication to advancing research has translated into patents, clinical studies, and a determined push toward commercialization. The journey towards leveraging probiotics for holistic well-being is clearly a driving force behind Ildong Bioscience's initiatives.
A Leap Towards International Recognition
"We have demonstrated the quality and safety of our probiotics raw materials through FDA GRAS certification," remarked an official from Ildong Bioscience. This achievement not only showcases the company's dedication to maintaining the highest standards but also positions it on a trajectory of global expansion and collaboration.
With the endorsement of the FDA GRAS certification, Ildong Bioscience is poised to make meaningful strides in international markets. By capitalizing on their differentiated raw materials, cutting-edge research, and tailored strategies, the company is primed to impact a broader audience and solidify its reputation as a pioneering force in the world of probiotics and functional foods.
As Ildong Bioscience continues to champion innovation and push the boundaries of probiotic research, its FDA GRAS certification serves as a resounding affirmation of its unwavering commitment to shaping the future of health and wellness on a global scale.